Back to GG Gilder Gagnon Howe & Co. LLC

RNLXY

Showing 0 of 16 quarters

Position history for GGGilder Gagnon Howe & Co. LLC's holdings in RENALYTIX PLC

No. Gilder Gagnon Howe exited its RNLXY (Renalytix) position in Q2 2024. Its Q1 2024 13F listed 761,108 shares worth $654,553. Gilder Gagnon Howe first reported RNLXY in Q3 2020 and held it in 15 quarterly 13F filings.

Current Value

-

Current Shares

-

Total Value Change

$0

Total Shares Change

0

No position history available for this security.

Other major holders of RNLXY: Fred Alger Management, LLC, FIL Ltd

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used